Assessing the Causal Relationship of Maternal Height on Birth Size and Gestational Age at Birth: A Mendelian Randomization Analysis by Zhang, Ge et al.
RESEARCH ARTICLE
Assessing the Causal Relationship of
Maternal Height on Birth Size and
Gestational Age at Birth: A Mendelian
Randomization Analysis
Ge Zhang1,2*, Jonas Bacelis3, Candice Lengyel2, Kari Teramo4, Mikko Hallman5,
Øyvind Helgeland6, Stefan Johansson6,7, Ronny Myhre8, Verena Sengpiel3, Pål
Rasmus Njølstad6,9, Bo Jacobsson8,10, Louis Muglia2*
1 Human Genetics Division, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of
America, 2 Center for Prevention of Preterm Birth, Perinatal Institute, Cincinnati Children’s Hospital Medical
Center and March of Dimes Prematurity Research Center Ohio Collaborative, Cincinnati, Ohio, United States
of America, 3 Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg,
Sweden, 4 Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki,
Finland, 5 PEDEGOResearch Center, University of Oulu and Department of Children and Adolescents,
Oulu University Hospital, Oulu, Finland, 6 KG Jebsen Center for Diabetes Research, Department of Clinical
Science, University of Bergen, Bergen, Norway, 7 Center for Medical Genetics and Molecular Medicine,
Haukeland University Hospital, Bergen, Norway, 8 Department of Genes and Environment, Division of
Epidemiology, Norwegian Institute of Public Health, Oslo, Norway, 9 Department of Pediatrics, Haukeland
University Hospital, Bergen, Norway, 10 Department of Obstetrics and Gynecology, Institute of Clinical
Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden
* Ge.Zhang@cchmc.org (GZ); Louis.Muglia@cchmc.org (LM)
Abstract
Background
Observational epidemiological studies indicate that maternal height is associated with ges-
tational age at birth and fetal growth measures (i.e., shorter mothers deliver infants at earlier
gestational ages with lower birth weight and birth length). Different mechanisms have been
postulated to explain these associations. This study aimed to investigate the casual rela-
tionships behind the strong association of maternal height with fetal growth measures (i.e.,
birth length and birth weight) and gestational age by a Mendelian randomization approach.
Methods and Findings
We conducted a Mendelian randomization analysis using phenotype and genome-wide sin-
gle nucleotide polymorphism (SNP) data of 3,485 mother/infant pairs from birth cohorts col-
lected from three Nordic countries (Finland, Denmark, and Norway). We constructed a
genetic score based on 697 SNPs known to be associated with adult height to index mater-
nal height. To avoid confounding due to genetic sharing between mother and infant, we
inferred parental transmission of the height-associated SNPs and utilized the haplotype
genetic score derived from nontransmitted alleles as a valid genetic instrument for maternal
height. In observational analysis, maternal height was significantly associated with birth
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length (p = 6.31 × 10−9), birth weight (p = 2.19 × 10−15), and gestational age (p = 1.51 ×
10−7). Our parental-specific haplotype score association analysis revealed that birth length
and birth weight were significantly associated with the maternal transmitted haplotype score
as well as the paternal transmitted haplotype score. Their association with the maternal
nontransmitted haplotype score was far less significant, indicating a major fetal genetic
influence on these fetal growth measures. In contrast, gestational age was significantly
associated with the nontransmitted haplotype score (p = 0.0424) and demonstrated a signif-
icant (p = 0.0234) causal effect of every 1 cm increase in maternal height resulting in ~0.4
more gestational d. Limitations of this study include potential influences in causal inference
by biological pleiotropy, assortative mating, and the nonrandom sampling of study subjects.
Conclusions
Our results demonstrate that the observed association between maternal height and fetal
growth measures (i.e., birth length and birth weight) is mainly defined by fetal genetics. In
contrast, the association between maternal height and gestational age is more likely to be
causal. In addition, our approach that utilizes the genetic score derived from the nontrans-
mitted maternal haplotype as a genetic instrument is a novel extension to the Mendelian
randomization methodology in casual inference between parental phenotype (or exposure)
and outcomes in offspring.
Introduction
Gestational age at birth (or simply gestational age), birth length, and birth weight are preg-
nancy outcomes associated not only with perinatal morbidity and mortality but also with long-
term adverse health outcomes, such as obesity [1], cardiometabolic disorders [2,3], and neuro-
psychiatric conditions [4]. Identifying the genetic and environmental factors that causally
influence these pregnancy outcomes will increase the understanding of the mechanisms under-
lying their association with diseases that occur later in life and thereby provide clues for possi-
ble prevention strategies [5,6].
Observational epidemiological studies have revealed several factors that are associated with
birth length, birth weight, and gestational age. Examples include maternal age, height, and
weight, offspring sex [7], maternal exposure to environmental hazards [8], and physiological or
psychological stresses [9]. In addition, genetic factors in both mothers and infants influence
these pregnancy outcomes [6,10,11]. Among these factors, maternal height has been repeatedly
reported to associate with fetal birth length [12], birth weight [7,13], and gestational age [14–
18]. Associations between paternal height and fetal birth length [19,20] as well as birth weight
[21,22] have also been reported, although there was no association with gestational age [15].
The associations between maternal height and pregnancy outcomes have been interpreted
based upon a mechanistic assumption—that maternal height sets a physical constraint on the
intrauterine environment (shorter women may have a small uterus size, limiting fetal growth) (Fig
1A—direct causal effect) [23]. Furthermore, adult height may reflect a mother’s cumulative social
and nutritional condition over her life course being an indicator of the persisting biological and/or
environmental factors that impact her offspring’s growth in utero (Fig 1B—indirect association)
[24]. The latter could be particularly important in low- and middle- income countries, where
nutrition-related factors may substantially restrict one’s growth [25]. These effects—physical
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constraints or confounding nutritional factors that jointly influence the fetal growth environment
—are commonly referred to as environmental effects (intrauterine effects) [26]. In addition to
these nongenetic mechanisms, the association between maternal height and birth outcomes could
be attributed to genetics in that the genetic polymorphisms that influence maternal height may
also have direct functional effects on pregnancy outcomes in fetus (Fig 1C—genetic effect)
[6,11,20,27,28].
Disentangling these different mechanisms underlying the association between maternal
height and pregnancy outcomes is important, as the knowledge may enhance our understand-
ing of the genetic and environmental etiology of these important pregnancy outcomes and how
they impact health. However, only a few study designs are capable of discerning these different
mechanisms and drawing causal inferences with regard to the association between maternal
height and pregnancy outcomes [26]. The existing literature on the genetic and environmental
impacts on pregnancy outcomes is inconsistent: some studies suggest that intrauterine factors
have the major role on birth weight [29], and some studies suggest that maternal height is
mainly a proxy for maternal socioeconomic conditions [24,30], while some studies suggest that
genetic factors have the major influence on pregnancy outcomes [20,28].
One approach to distinguish the contributions of intrauterine environmental effects from
direct genetic influences is to compare maternal–offspring and paternal–offspring associations.
Stronger maternal–offspring than paternal–offspring associations would imply intrauterine
effects, whereas similar maternal and paternal associations with a birth outcome would suggest
predominant genetic effects [31,32]. Previous studies have indicated that both maternal and
paternal height are associated with birth length [20] and birth weight [22,28], which suggest
substantial fetal genetic impact on early fetal growth. In contrast, gestational age was reported
to be associated with maternal height but not with paternal height [15].
Fig 1. Schematic representation of various causal mechanisms that can lead to the observational associations betweenmaternal height and
pregnancy outcomes. (A) Direct causal effect of maternal height on pregnancy outcomes. (B) Associations of social and nutritional confounders that have
impacts on both maternal height and pregnancy outcomes. (C) Fetal genetics that directly influences pregnancy outcomes.
doi:10.1371/journal.pmed.1001865.g001
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More recently, Eaves et al. [33] extended the genome-wide complex trait analysis (GCTA)
method to partition offspring phenotypic variance into components attributable to fetal geno-
type, maternal effects, and the covariance between these two. By applying this method to the
Avon Longitudinal Study of Parents and Children (ALSPAC) cohort, they found that fetal
genetics and maternal effect explain 13% and 11%, respectively, of the variance in birth length
[33].
Another approach to draw causal inference is Mendelian randomization [34,35], which uti-
lizes genetic variants associated with the parental phenotype/exposure as an instrumental vari-
able to probe the causal effect of parental phenotype/exposure on outcomes in their offspring
[26,36]. As an “instrumental variable” technique [37], the validity of this method depends on
two conditions: (1) relevance—the genetic instrument must be associated with the intermediate
phenotype or risk factor with enough strength—and (2) exogeneity—the genetic instrument
must not be related to the outcome by means other than the intermediate phenotype. Specifi-
cally, the latter assumption requires that the genetic instrument is unrelated to confounders
and that the genetic instrument does not influence the outcome through other mechanisms
(biological pleiotropy) [38].
Box 1. Assumptions of Mendelian Randomization Study
Mendelian randomization is a type of instrumental variable analysis that uses a genetic
instrumental variable (G) to examine the causal effect of an exposure or an intermediate
phenotype (X) on an outcome (Y). In our study, we used the height genetic score as the
genetic instrument (G) to probe the causal relationship between maternal height (X) and
various pregnancy outcomes (Y). The validity of this approach requires the following
assumptions to be met:
1. G is associated with X with enough strength, which is called the instrument relevance
in statistical terms.
2. G is related to Y only through X, not through other environmental confounding fac-
tors or biological pleiotropy. This assumption is also referred to as instrument
exogeneity.
In this study, the first assumption was achieved by using a genetic score constructed
based on a large number of height-associated SNPs. The genetic score explains a substan-
tial fraction of variance in maternal height and therefore makes a powerful genetic
instrument. Because G is randomly assigned to individuals at birth, G is generally not
associated with nongenetic confounders. However, it is hard to completely exclude the
possibility of biological pleiotropy, i.e., Gmay influence Y through biological mecha-
nisms other than X.
In the inference of a causal relationship between a parental phenotype and an out-
come in offspring, parental genotype is an invalid instrument if the offspring genotype is
not appropriately adjusted for, because half of the parental alleles are transmitted to off-
spring and may directly influence the outcome in offspring. To overcome this problem,
we used a genetic score based on the nontransmitted haplotype to index the maternal
height.
Maternal Height and Birth Characteristics
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Since genetic variants typically explain a small proportion of the phenotypic variance, con-
ventional Mendelian randomization studies often require large sample sizes [39]. Using height
as an example, the strongest single SNP association only explains<0.5% of the observed varia-
tion in height [40,41]. Thus, a Mendelian randomization study using a single SNP would
require hundreds of thousands of samples [42]. One solution to this limitation is to use multi-
ple associated SNPs obtained from large-scale genome-wide association studies (GWAS) to
construct more powerful genetic instruments [43–45].
When utilizing the Mendelian randomization to draw causal inference between parental
phenotype and outcomes in offspring, the method is further complicated by the transmission
of parental alleles, and therefore, the fetal genotype needs to be adjusted for to avoid the con-
founding due to genetic sharing between parents and offspring [26,35]. Using this method,
Lawlor et al. [46] explored the causal effect of maternal body-mass index (BMI) on childhood
obesity. We have not seen this approach being used to examine the causal mechanism underly-
ing the association between maternal height and pregnancy outcomes.
In this study, we first examined the observational associations between maternal height and
birth length, birth weight, and gestational age at birth and then assessed the causal effect of
maternal height on these measurements by a Mendelian randomization approach. We con-
structed genetic score based on 697 height-associated SNPs as the instrumental variable for
maternal height. We inferred parental transmission of the height-associated SNPs and utilized
the haplotype genetic score derived from the nontransmitted alleles as a valid genetic instru-
ment and thus avoided the interference by genetic transmission in causal inference. Using this
modified Mendelian randomization approach, we evaluated the causal relationship of maternal
height on birth size and gestational age at birth in 3,485 mother/infant pairs collected from
three Nordic countries (Finland, Denmark, and Norway).
Methods
Description of Study Cohorts
We used the phenotype and genome-wide SNP data of up to 3,485 mother/infant pairs from
birth cohorts collected from three Nordic countries (Table 1).
The Finnish cohort (FIN) was collected for a genetic study of preterm birth [47]. Briefly,
whole blood samples were collected from ~800 mother/child pairs from the Helsinki (southern
Finland) University Hospitals between 2004 and 2014. All of these studied samples are of Finn-
ish descent. Crown-rump length at the first ultrasound screening between 10+ and 13 wk was
used to determine the gestation and the due date. The study was approved by the Ethics Com-
mittee of Oulu University Hospital and that of Helsinki University Central Hospital. Written
informed consent was given by all participants.
The Mother Child Cohort of Norway (MoBa) is a nationwide Norwegian pregnancy cohort
study administered by the Norwegian Institute of Public Health. The study includes more than
Table 1. Description of study cohorts.
Cohort Full Name Mother/Infant Pairs (Term/Preterm)* Genotyping Platform
FIN Finnish (Helsinki) Birth Cohort 544/239 Affymetrix 6.0 + Illumina
MoBa Norwegian Mother and Child Cohort 525/493 Illumina Human660W
DNBC Danish National Birth Cohort 960/724 Illumina Human660W
* Preterm birth was deﬁned as gestational age less than 37 wk; term birth was deﬁned as gestational age larger than 38 wk in this study.
doi:10.1371/journal.pmed.1001865.t001
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107,000 pregnancies recruited from 1999 through 2008. Gestational age was estimated by ultra-
sound at gestational weeks 17–19. In the few participants without ultrasound dating, gestational
age was estimated using the date of the last menstrual period. For the current study, we used the
mother-child pairs that were selected from version 4 of the MoBa cohort, which included a total
of 71,669 pregnancies. Singleton live-born spontaneous pregnancies with mothers in the age
group 20–34 y were selected. Pregnancies involving preexisting medical conditions and pregnan-
cies with complications, as well as pregnancies conceived by in vitro fertilization, were excluded
from the study. Random sampling was done from two gestational age ranges of 154–258 d
(cases) and 273–286 d (controls). In total, 3,121 mothers and children were genotyped [48]. Of
the 2,977 samples that passed quality control (QC), 1,018 mother/child pairs were identified and
used in this study. All parents gave informed, written consent. The study was approved by the
Regional Committee for Medical Research Ethics South-East, Norway.
The Danish National Birth Cohort (DNBC) followed over 100,000 pregnancies between
1997 and 2002, with extensive epidemiologic data recorded on health outcomes in both mother
and child [49]. The current study used the data downloaded from the Database of Genotypes
and Phenotypes (dbGaP) (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_
id = phs000103.v1.p1), which contains data from a genome-wide case/control study using
approximately 1,000 preterm mother-child pairs (gestational age between 22–37 wk) from the
DNBC, most with spontaneous onset of labor or preterm premature rupture of membranes
(PPROM), along with 1,000 control pairs in which the child was born at ~40 wk gestation. Ges-
tational age in this cohort was estimated by combining all available information from multiple
sources: self-reported date of last menstrual period, self-reported delivery date, and gestational
age at birth registered in the Medical Birth Register and the National Patient Register. Of the
3,838 DNBC samples with genotype data, 3,712 samples passed the genotype QC, from which
we identified 1,684 mother/child pairs and used them in the current study.
All the preterm births included in this study were spontaneous. Obstetrical induction of
labor, placental abnormalities, preeclampsia, congenital malformations, and multiple births
were excluded. Pregnancies involving preexisting medical conditions known to be associated
with preterm birth and pregnancies with complications were also excluded.
Genotyping and Imputation
Genome-wide SNP genotyping was conducted using different SNP arrays (Table 1). Specifi-
cally, for FIN, genotyping was conducted using Affymetrix 6.0 (Affymetrix, California, United
States) and various other Illumina arrays (Illumina, California, United States). For the Affyme-
trix SNP Array 6.0, genotype calls were determined using the CRLMM algorithm [50,51]
among chips that passed the vendor-suggested QC (Contrast QC> 0.4). For the Illumina
chips, the genotype calling was conducted using Illumina’s genotyping module v1.94 in the
GenomeStudio v2011.1. The 3,121 samples from the MoBa cohort were genotyped using the
Illumina Human660W-Quadv1_A bead chip (Illumina), and the genotype calls were deter-
mined using CRLMM algorithm. The DNBC samples were also genotyped using the Illumina
Human660W-Quadv1_A bead chip, and the genotype calls were determined using the
CRLMM algorithm based on the chip intensity files (IDAT files) obtained from dbGaP.
Similar QC procedures were used across the three studies. Briefly, individuals with incorrect
sex assignment, excessive heterozygosity, or low call rate (<98%) were excluded from further
analysis. Incorrect mother-child relationships and cryptic relatedness were detected by iden-
tity-by-descent (IBD) sharing estimated from genome-wide SNPs. Non-European samples
were identified and excluded using principal component analysis (PCA) anchored with 1000
Genomes or HapMap reference samples. At marker level, SNPs with low call rate (<98%), low
Maternal Height and Birth Characteristics
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minor allele frequency (<0.03), or significant deviation from Hardy-Weinberg equilibrium
(p< 1 × 10−4) were excluded.
Following the QC procedures, we conducted genome-wide imputation using the reference
haplotype data extracted from the 1000 Genomes Project (integrated phase I release) [52]. A
standard two-step imputation procedure was followed: the genotype data was first prephased
using Shapeit2 software [53], and then the estimated haplotypes were used to impute untyped
SNPs in mothers and infants using the reference haplotypes extracted from the 1000 Genomes
Project (integrated phase I release) by either Minimac [54] (FIN) or Impute2 [55] (MoBa and
DNBC).
Genetic Score Analysis
We selected the 697 SNPs associated with adult height from the stage II meta-analysis [40] of
GIANT studies (http://www.broadinstitute.org/collaboration/giant) to construct a weighted
genetic score and use it as a genetic instrument of height. The list of height-associated SNPs
and their effect size estimates were extracted from the supplementary table of reference [40].
The reported effect sizes were estimated using an approximate conditional and joint analysis,
which appropriately accounts for the linkage disequilibrium (LD) between SNPs [56]. The
weighted genetic score was constructed as S = ∑biGi, where Gi = 0, 1 or 2 (for genotype-based
genetic score) or Gi = 0 or 1 (for haplotype-based genetic score, see below), which indicates the
number of reference alleles for a specific SNP, and bi is the estimated allelic effect.
Fig 2. Maternal transmission of alleles and haplotype scores.We inferred maternal transmission of
alleles (M1! C1) and constructed haplotype scores: M1 and C1, maternal transmitted haplotype score; M2,
maternal nontransmitted haplotype score; and C2, paternal transmitted haplotype score.
doi:10.1371/journal.pmed.1001865.g002
Maternal Height and Birth Characteristics
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Determining Parental Origin
A potential challenge in utilizing Mendelian randomization to study causal effects of parental
exposures on outcomes in offspring is the confounding due to shared genetics between parents
and offspring [26,46]. Using our case as an example, maternal genotype-based genetic score
(parental genotype) is not a valid instrument for maternal height (parental phenotype) because
the transmitted maternal alleles can influence the fetal phenotypes (e.g., birth length or weight)
through direct genetic effects in the infants (Fig 1C). To overcome this problem, we inferred
maternal transmission of height-associated alleles and utilized the nontransmitted haplotype
genetic score as a genetic instrument to avoid the interference by genetic transmission (Fig 2).
Specifically, for a particular SNP, we inferred allelic transmission (from mother to child) based
on either direct comparison of genotypes or local haplotype sharing. If either or both of mother
and child are homozygotes, the allele transmission can be unambiguously determined from
their genotypes. When both mother and child were heterozygotes, we constructed a long-range
(up to 1 Mb) local haplotype around the SNP under consideration and compared haplotype
sharing to determine allelic transmission. With the inferred allelic transmission of the height-
associated SNPs, we divided the maternal genetic score into two haplotype components (Fig 2):
“maternal transmitted haplotype score” (M1), which was calculated from the transmitted
alleles, and “maternal nontransmitted haplotype score” (M2), which was calculated from the
nontransmitted alleles in the mothers. Accordingly, the fetal genetic score was divided into
“maternal transmitted haplotype score” (C1) and “paternal transmitted haplotype score” (C2).
For example, if we use Ai and Bi to denote the transmitted and nontransmitted alleles of SNP i
in a mother, the maternal transmitted haplotype score (M1) was calculated as ∑biAi and the
maternal nontransmitted haplotype score (M2) was ∑biBi. Obviously, the genotype score equals
∑biGi = ∑biAi + ∑biBi, since the genotype is the summation of the two alleles (Gi = Ai + Bi). The
two fetal haplotype scores (C1 and C2) were calculated in the same way, and C1 = M1. Associa-
tion between the maternal transmitted haplotype score (M1/C1) and a fetal phenotype can be
explained as either intrauterine effects (Fig 1A) or direct genetic influence of fetal genetics (Fig
1C), since the transmitted alleles can have genetic influence in both mothers and infants.
Whereas the association between the maternal nontransmitted haplotype score (M2) and a
fetal phenotype is a clear indication of causal effects of the maternal phenotype itself (Fig 1A),
the association between the paternal transmitted haplotype score (C2) and a fetal phenotype
should represent fetal genetic effect (Fig 1C).
Table 2. Association betweenmaternal height and pregnancy outcomes.
Cohort Birth Length Birth Weight Gestational Age
beta* se p-value beta se p-value beta se p-value
FIN 0.0536 0.0113 2.29E-06 11.3 2.42 3.48E-06 0.293 0.142 0.0393
MoBa 0.0379 0.0109 0.00054 6.31 2.01 0.00171 0.303 0.104 0.0035
DNBC$ 11.1 1.88 4.12E-09 0.400 0.102 9.34E-05
meta 0.0455 0.00783 6.31E-09 9.46 1.19 2.19E-15 0.340 0.0647 1.51E-07
p_het# 0.317 0.149 0.746
* Beta is the unstandardized coefﬁcient, which shows the estimated changes in pregnancy outcomes per 1 cm increase in maternal height.
$ DNBC does not have birth-length data.
# p_het: heterogeneity test p-value.
doi:10.1371/journal.pmed.1001865.t002
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Statistical Analyses
We first assessed statistical associations between maternal phenotypes (i.e., height, weight,
BMI, and age) and pregnancy outcomes (i.e., birth length, birth weight, and gestational age)
using linear regression. Associations between various height genetic scores and maternal phe-
notype as well as pregnancy outcomes were examined by regression analysis. In the regression
analyses of birth length and birth weight, maternal age, fetal gender, and gestational age were
included as covariates. In the analysis of gestational age, only maternal age and fetal gender
were included. To estimate the magnitude of causal effects of maternal height on pregnancy
outcomes, we performed instrumental variable analysis using the two-stage least squares
approach [57]. Three genetic instrumental variables for maternal height were evaluated: (1)
maternal genotype-based genetic score without controlling for fetal genetic score (method 1),
(2) maternal genotype-based genetic score while controlling for fetal genetic score (method 2),
and (3) maternal nontransmitted haplotype score (method 3). Fixed-effect meta-analysis was
used to combine the results from different studies. Between-study heterogeneity was tested by
Cochran’s Q test.
Results
Association between Maternal Height and Pregnancy Outcomes
Summary statistics of the phenotype data of the three cohorts are provided in S1 Table and S2
Table. We observed significant associations between maternal height and birth weight, birth
length, and gestational age at birth separately in all the three studied cohorts (Table 2). The
meta-analysis p-values were 6.31 × 10−9 (birth length), 2.19 × 10−15 (birth weight) and
1.51 × 10−7 (gestational age).
Table 3. Association betweenmaternal height genetic score andmaternal height.
Cohort Maternal Genotype Genetic Score
Beta se p-value r2
FIN 5.67 0.397 3.48E-41 0.209
MoBa 5.54 0.347 3.82E-51 0.207
DNBC 5.80 0.289 3.62E-80 0.202
meta 5.69 0.194 2.75E-189
p_het 0.841
doi:10.1371/journal.pmed.1001865.t003
Table 4. Association between genotype height genetic scores and pregnancy outcomes based onmeta-analysis.
Genotype Score Birth Length Birth Weight Gestational Age
beta se p-value beta se p-value beta se p-value
Maternal 0.382 0.0916 3.04E-05 75.4 14.2 1.19E-07 1.34 0.760 0.0769
Fetal 0.535 0.0916 5.40E-09 101 14.3 1.84E-12 0.349 0.769 0.650
Maternal (Adjusted)* 0.135 0.108 0.214 30.6 16.8 0.0697 1.62 0.902 0.0717
* Adjusted by fetal genetic score.
doi:10.1371/journal.pmed.1001865.t004
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Association between Maternal Height Genetic Score and Maternal
Height
As expected, the maternal genetic score was significantly associated with maternal height
(meta p = 2.75 × 10−189) and could explain a large fraction (~20%) of the observed variance in
maternal height in all of the three cohorts (Table 3). The transmitted haplotype score and the
nontransmitted haplotype scores explained similar proportions of variance (~10%) (S3 Table).
At single SNP level, the estimated effect sizes (on maternal height) of the height-associated
SNPs based on our studies were highly correlated with the reference study (Pearson’s ρ = 0.41,
p< 2 × 10−16).
Association between Maternal as well as Fetal Height Genetic Scores
and Pregnancy Outcomes
The maternal genetic score showed consistent significant associations with both birth length
(meta p = 3.04 × 10−5) and birth weight (meta p = 1.19 × 10−7) in the studied cohorts. The fetal
height genetic score was even more significantly associated with birth length (meta
p = 5.40 × 10−9) and birth weight (meta p = 1.84 × 10−12), which indicated direct fetal genetic
Fig 3. The estimated effect (in mothers) of the height-associated SNPs on gestational age was
correlated with reported effect size on adult height.
doi:10.1371/journal.pmed.1001865.g003
Table 5. Association between haplotype genetic scores and pregnancy outcomes.
Haplotype Score* Birth Length Birth Weight Gestational Age
beta se p-value beta se p-value beta se p-value
M1 (C1) 0.534 0.136 8.08E-05 145 20.9 4.02E-12 0.587 1.12 0.601
M2 0.270 0.132 0.0405 17.1 20.4 0.404 2.204 1.09 0.0424
C2 0.557 0.129 1.61E-05 63.8 20.3 0.00165 0.203 1.08 0.851
* M1 (C1), maternal transmitted haplotype score; M2, maternal nontransmitted haplotype score; C2, paternal transmitted haplotype score.
doi:10.1371/journal.pmed.1001865.t005
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influence of height-associated SNPs on fetal growth. After adjustment for fetal genetic score,
the associations between maternal genetic score and birth length or birth weight were no longer
significant (Table 4 and S4 Table).
Given the highly significant association between fetal genetic score based on adult height-
associated SNPs with both birth length and birth weight, we further examined single SNP asso-
ciations of these adult height-associated SNPs with both birth length and birth weight in the
infants. As indicated by the quantile-quantile (Q-Q) plots (S1 Fig), there was a general inflation
of the association test statistics (λ = 1.137 and 1.175 for birth length and weight, respectively),
indicating that a substantial fraction of the height-associated SNPs were also associated with
birth length or birth weight in fetus. There was also a marginally significant correlation
between the estimated effect size of these SNPs on birth length and the reported effect size on
adult height (Pearson’s ρ = 0.073, p = 0.055). However, the correlation of the estimated effect
size of these SNPs on birth weight and the reported effect size on adult height was not signifi-
cant (Pearson’s ρ = 0.041, p = 0.283).
The pattern of associations for gestational age was different from those observed in birth
length or birth weight. There was some evidence of association between maternal height
genetic score and gestational age overall (meta-analysis p = 0.077), preferably in the DNBC
cohort (p = 0.047). However, the fetal height genetic score was not significantly associated with
gestational age. After adjustment for fetal genetic score, the maternal height genetic score was
still marginally associated with gestational age (meta p = 0.072). Further single marker associa-
tion (between maternal genotype and gestational age) analysis also showed some inflation of
association test statistics (λ = 1.054, S2 Fig) and a significant correlation between the estimated
effect size of these SNPs on gestational age and the reported effect size on adult height
Table 6. Pairwise correlation among genetic scores.
Score* M M1 M2 C C2
M
M1 (C1) 0.715 (0)
M2 0.734 (0) 0.051 (0.00128)
C 0.539 (8.63e-277) 0.704 (0) 0.086 (1.66e-07)
C2 0.067 (3.41e-05) 0.024 (0.0770) 0.073 (7.87e-06) 0.726 (0)
* M, maternal genotype score (M1 + M2); M1 (C1), maternal transmitted haplotype score; M2, maternal nontransmitted haplotype score; C, fetal genotype
score (C1 + C2); C2, paternal transmitted haplotype score.
doi:10.1371/journal.pmed.1001865.t006
Table 7. Results of instrumental variable analysis.
Method* Birth Length Birth Weight Gestational Age
beta se p-value beta se p-value Beta se p-value
Method 1 0.0692 0.0161 1.64E-05 13.4 2.53 1.21E-07 0.280 0.135 0.0385
Method 2 0.0298 0.0214 0.164 5.70 3.30 0.0837 0.387 0.176 0.0276
Method 3 0.0501 0.0236 0.0336 2.47 3.70 0.504 0.440 0.194 0.0234
Method 4 0.0418 0.0257 0.104 0.486 3.96 0.170 0.475 0.209 0.0232
* Method 1 and method 2 use maternal genotype-based genetic score (M) as the instrument variable for maternal height without (method 1) or with
(method 2) controlling for fetal genetic score (C). Method 3 utilizes maternal nontransmitted haplotype score (M2) as a valid instrument for maternal height.
Method 4 uses maternal nontransmitted haplotype score (M2) as the instrument variable and further adjusts for possible bias due to assortative mating by
controlling for maternal and paternal transmitted scores (M1/C1 and C2) as covariates.
doi:10.1371/journal.pmed.1001865.t007
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(Pearson’s ρ = 0.152, p = 5.58 × 10−5) (Fig 3), indicating the effect of these height-associated
SNPs on gestational age is projected through a common intermediate phenotype (i.e., height)
rather than different biological (pleiotropic) mechanisms.
Association between Haplotype Height Genetic Scores and Pregnancy
Outcomes
Our parental haplotype genetic score analysis revealed significant associations of both maternal
transmitted haplotype score and paternal transmitted haplotype score with birth length and
birth weight (Table 5 and S5 Table). However, the associations between the maternal nontrans-
mitted haplotype scores with these two fetal growth traits were far less significant (meta
p = 0.0405 and 0.404 for birth length and birth weight, respectively). In addition, although both
were significantly associated with birth weight, the effect of maternally transmitted alleles was
significantly larger than paternally transmitted alleles (p = 0.0053). This difference of effect was
not observed for birth length. In contrast, the maternal nontransmitted haplotype score (M2),
but not the parental transmitted score (C2), showed significant associations with gestational
age (meta p = 0.0424), which suggests cross-generational effect of maternal height SNPs on ges-
tational age through an intermediate phenotype (maternal height) but not through genetic
inheritance.
Although not a primary objective of this current study, we also examined the pairwise corre-
lations between the various genetic scores (Table 6 and S6 Table). In addition to those highly
significant correlations due to genetic sharing between parents and their offspring, such as cor-
relations between maternal and fetal genetic scores, we also observed significant positive corre-
lations between the two maternal haplotype genetic scores (transmitted and nontransmitted
scores) and between the paternally transmitted score and the maternal scores, which were most
probably due to assortative mating based on height.
Instrumental Variable Analysis
To estimate the causal effect of maternal height on the pregnancy outcomes, we performed
instrumental variable analysis (Table 7 and S7 Table). For comparison purposes, we tested
three different methods using either maternal genotype-based genetic score (method 1 and 2)
or maternal nontransmitted haplotype score (method 3) as instrument variables. For birth
length and birth weight, the causal inference based on method 1 (using maternal genotype-
based genetic score without controlling for fetal genetic score) were highly significant. How-
ever, the significance diminished after controlling for fetal genetic score (method 2) or when
using maternal nontransmitted haplotype score as the genetic instrument (method 3). Consis-
tent with our genetic score association analyses, these results again suggested that fetal genetic
effect instead of causal effect of maternal height itself was the main driving force behind the
observed associations between maternal height and fetal growth measures. Although the infer-
ence based on the maternal nontransmitted haplotype score (method 3) indicated some signifi-
cant causal influence of maternal height on birth length (p = 0.0336). In contrast, all three
methods revealed consistent and significant causal effect of maternal height on gestational age,
with every 1 cm increase in maternal height resulting in ~0.4 more gestational d. To exclude
the possible bias introduced by assortative mating (i.e., due to the correlation between haplo-
type scores), we performed instrumental variable analysis with maternal and paternal transmit-
ted scores (M1/C1 and C2) adjusted as covariates (method 4). The results were similar to those
obtained by method 3.
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Discussion
Summary of Major Findings
While the extremes of birth size, particularly birth weight, and gestational age at birth are
important global contributors to infant mortality, more modest deviations in these parameters
have been repeatedly linked to risk for adult disorders such as type 2 diabetes mellitus, hyper-
tension, and cardiovascular disease [58–60]. Thus, understanding the determinants of fetal
growth and the duration of pregnancy are essential to improve both newborn and later-in-life
health. Epidemiological evidence has suggested that these birth outcomes are shaped by intra-
uterine environment, but the relative contribution of maternal genetic, fetal genetic, and non-
genetic factors that may drive epigenetic physiological adaptations remains incompletely
understood. Moreover, should fetal genetics shape these outcomes, their direct involvement in
the risk for the adult diseases, as well, is an intriguing possibility. Recently, to better understand
normal fetal growth in healthy pregnancy, a multinational longitudinal assessment has been
reported [61]. These data demonstrate similar average growth profiles across geographic popu-
lations but do not define the mechanisms for variability within a given population.
In this study, we observed the consistent associations between maternal height and birth
length, birth weight, and gestational age in each of the three study cohorts. The estimated effect
sizes of the observed associations were respectively ~0.05 cm/cm for birth length, ~10 g/cm for
birth weight, and ~0.34 d/cm for gestational age per 1 cm change in maternal height, which are
in the same range as previous reports for fetal growth [20] and gestational age [15]. We then
disentangled causal relationships underlying these observational associations.
Based on an extensive list of height-associated SNPs (n = 697) reported by a recent large
GWAmeta-analysis [40], we constructed a height genetic score as a powerful genetic instru-
ment for maternal height. In our study samples, the genotype-based genetic score explained a
substantial fraction (~20%) of variance in maternal height. This percentage was even larger
than that (~16%) reported in the original study [40], which is likely due to the homogeneity of
our samples (i.e., all females with northern European origin and a more restricted age distribu-
tion). Our previous studies have shown that the height genetic score explained larger variance
in females than males [62,63].
We observed significant associations of maternal height genetic score with birth length,
with birth weight, and, to a lesser extent, with gestational age. As the genetic score captures the
genetic variation in maternal height, these significant associations suggested either direct causal
influence (Fig 1A) of maternal height or fetal genetic effect (Fig 1C) rather than confounding
effects (Fig 1B), although the latter mechanism could not be excluded. It should be emphasized
that maternal genetic score is not a valid instrument for maternal height, unless adjusted for
fetal genotype; thus, it cannot be used to differentiate the causal effect of maternal height (Fig
1A) from fetal genetic effect (Fig 1C).
We further probed the causal impacts of maternal height using genetic instruments either
based on maternal genetic score without or with adjustment for fetal genetic score (method 1
and 2) and maternal nontransmitted haplotype score (method 3). The results strongly sug-
gested that the observed correlations between maternal height and birth length or birth weight
were mainly due to fetal genetic effects but not due to nongenetic intrauterine effect (i.e.,
maternal height as an environmental factor that casually influences fetal growth). Multiple
lines of evidence consistently supported this conclusion.
First, we observed significant association of fetal genetic score with birth length and birth
weight, and after controlling for fetal genetic score, the associations between maternal genetic
score with birth length and weight were no longer significant, which suggests substantial fetal
genetic influence. This observation was in line with previous studies, which showed that the
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magnitudes of associations between paternal height with either birth length or birth weight
were comparable to maternal height [20,21,64]. Genetic analyses of parent-offspring data
[6,11] also suggested fetal genetics explain more variation in birth size.
Second, our haplotype-based genetic score analysis showed that both maternal transmitted
genetic score and paternal transmitted genetic score were highly significantly associated with
birth length and birth weight, but the nontransmitted score was not (particularly for birth
weight), which again indicated that maternal height has relatively minimal effect on birth
length or birth weight if not transmitted genetically. The nontransmitted score was marginally
associated with birth length, which suggests some direct causal effect of maternal height on
birth length, and the estimated causal effect size was similar to the observational effect (~0.05
cm change in birth length per 1 cm change in maternal height).
Thirdly, our single marker analysis indicated that those adult height-associated SNPs were
excessively associated with birth length and birth weight in fetus, but the estimated effect sizes
of these SNPs on birth length and birth weight were not well correlated with their effect on
maternal height, which indicated direct but different functional effects of these SNPs on fetal
growth rather than a common causal effect mediated through maternal height. The inference
of the parental transmission in mother-child pairs also allows us to examine parent-of-origin
effects of those height-associated SNPs on birth length and weight. Our results showed exces-
sive differences between the maternal and paternal transmitted alleles. For birth weight, the
effect sizes of the maternal transmitted alleles were generally larger than paternal transmitted
ones.
We also performed the analysis using gestation-adjusted birthweight percentiles (converted
to z-scores) as the outcome and obtained similar results (S8 Table). This evidence collectively
suggests that birth weight and birth length are mainly defined by fetal genetics. Therefore, it is
difficult to define abnormality of fetal growth in a general term (e.g., by deviation from popula-
tion mean) without taking genetic variance into account. It should be noted that the samples of
the current study were collected from high-resource northern European countries, with pre-
sumably good nutrition throughout childhood, adolescence, and pregnancy, enabling the
mothers and their infants to grow to their full genetic potential. This fact might account for
why we observed a predominant influence of genetic factors on birth size in this study. The
conclusion may not be directly transferrable to low- or middle-income countries, where mal-
nutrition may substantially constrain one’s growth and significantly change the association
between maternal height and fetal growth [24,25].
In contrast with the findings in birth length and birth weight, we observed evidence that
suggested gestational age at birth might be causally influenced by maternal height, in which
case maternal height might operate as an important factor that shapes the intrauterine environ-
ment and influence the gestational age. Again, this conclusion was supported by multiple lines
of evidence: (i) gestational age was (marginally) associated with maternal height genetic score
but not with fetal height genetic score, and after adjustment for fetal genetics, the association
between gestational age and maternal height genetic score were still significant; (ii) gestational
age was associated with maternal nontransmitted haplotype genetic score, which indicated the
effect of maternal height on gestational age was transmitted through phenotypic causal mecha-
nism rather than genetic inheritance (i.e., transmission of alleles); (iii) the estimated causal
effect of 0.4 d/cm of maternal height on gestational age was similar to the size from observa-
tional association; and (iv) single-marker analysis indicated that those adult height SNPs were
excessively associated with gestational age, and the estimated effect sizes of these SNPs (in
mothers) on gestational age, although relatively low, were correlated with their effect on mater-
nal height, which suggested the effect of these SNPs is projected through a common intermedi-
ate (i.e., maternal height) rather than through SNP-specific pathways (biological pleiotropy).
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We also performed analysis using preterm status as a dichotomous outcome, and the results
(S9 Table) indicated that shorter maternal height is a risk factor for preterm birth (observa-
tional association p = 3.77 × 10−6, with an estimated 3% increase in risk if the mothers are 1 cm
shorter). This result was consistent with a recent epidemiology study [18]. Genetic score analy-
sis also showed significant association between preterm birth risk and the nontransmitted hap-
lotype score (p = 0.0456), which suggests that maternal height causally influences preterm birth
risk.
We recognize that the association between maternal non-transmitted haplotype score and
gestational age was only modestly significant (meta p = 0.0424), and it was mainly driven by
the DNBC cohort (p = 0.018) and was not significant in the other two cohorts. Also, gestational
age in the DNBC cohort was estimated by combining information from self-reported data and
gestational age reported in birth registry, while it was estimated by ultrasound in the other two
cohorts. However, our meta-analysis did not reveal any sign of inconsistency—the confidence
intervals of the estimates from different cohorts overlap and the p-value for the heterogeneity
test was not significant. Nevertheless, the error-free validity of this association needs to be con-
firmed by further replication studies in independent cohorts.
Using Parental Non-transmitted Haplotype Genetic Score in Causal
Inference
Inference of parental transmission and analysis of parental-specific haplotype genetic scores is
an important advantage of our current study. We are unaware of any published studies using
this approach to disentangle the causal relationships between a parental exposure and out-
comes in offspring. The distinction between the transmitted versus the nontransmitted mater-
nal alleles can differentiate whether the causal mechanism is a phenotypic one (Fig 1A) or a
genetic one (Fig 1C). Using nontransmitted haplotype genetic score can prevent the confound-
ing due to genetic sharing between parents and offspring. Furthermore, the distinction between
the maternal- and paternal-transmitted alleles can be used to study parent-of-origin effects,
which are especially important in early-development phenotypes [65].
The maternal genotype-based genetic score (i.e., maternal height score) built on multiple
associated SNPs, while capturing more variance in maternal height, is not a valid instrument
(method 1) unless the genetic effect of those SNPs in offspring can be appropriately adjusted
for. However, complete adjustment for the fetal genetic effect of multiple SNPs could be diffi-
cult to achieve. We recognized that the weighted height genetic score in infants might not cor-
rectly summarize the genetic effect of the height-associated SNPs on pregnancy outcomes,
since the weights of the SNPs were based on their effect sizes on adult height. As indicated by
our single SNP analyses, the estimated effect sizes of these SNPs on birth length and birth
weight were poorly correlated with the reported effect sizes on adult height. Considering this
fact, using maternal height genetic score as genetic instrument, even adjusted for offspring
genotype by fetal genetic score (method 2), might be inappropriate and could lead to biased
estimate in causal inference. In contrast, our approach that used the nontransmitted haplotype
genetic score (method 3) did not suffer from this problem.
There are several caveats for our analytical approach: (1) high-density SNP data are required
to construct long-range haplotypes in mothers and children when the allele transmission can-
not be unambiguously determined from allelic states when both mother and child are heterozy-
gote, and (2) in certain scenarios, the mutual independence between the transmitted and
nontransmitted allele(s) cannot be assumed, e.g., in case of assortative mating dependent on
the phenotype under study. The first limitation will require genotype data on additional SNPs
around the SNPs used as genetic instrument, which is not a problem when genome-wide SNP
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data are available. The second limitation might introduce bias in causal inference, since the
nontransmitted haplotype genetic score could correlate with the transmitted one. Intuitively,
the extent of the bias due to assortative mating should be proportional to the correlation
between haplotype genetic scores and the correlation between the (maternal and paternal)
transmitted haplotype genetic scores and the pregnancy outcome, and therefore, it would be
small because the correlation due to assortative mating is generally low.
Biological pleiotropy is always a potential issue that could undermine the validity of Mende-
lian randomization causal inference [38]. Complete exclusion of biological pleiotropy requires
a strong assumption that the genetic instrument is associated with the outcome only through
the intermediate phenotype but not through other biological mechanisms. Generally, it is not
possible to prove this assumption [66], especially when a large number of genetic variants are
used to construct the genetic instrument [43]. Some empirical evidences can help rule out
major violations of the “no pleiotropy” assumption. For example, multiple genetic variants
showing consistent results may support a common causal path through the intermediate phe-
notype that the variants are associated with [66]. In this study, the significant correlation
between the estimated effect size of the height-associated SNPs on gestational age and the
reported effect size on adult height strongly suggested consistent causal inference across multi-
ple SNPs.
From a study design perspective, there are number of limitations of our study. We tried to
infer a mechanistic causal relationship between maternal height and several pregnancy out-
comes. For this type of study, a random sample from target population is usually preferred.
The three included studies were all case/control studies, in which the samples were enriched
for mother/child pairs with short gestational age (<37 wk). In addition, the case/control sam-
pling also broke down the normal distributions of the traits, with the distribution of the gesta-
tional age broken down into two segments (one for controls and one for cases). Similarly, the
distributions of birth length and birth weight have two modes. However, after adjustment for
gestational age, birth weight and length followed normal distributions. Yet, there is no easy
method to transform the two-segmented distribution of gestational age into normal. This prob-
lem might undermine the validity of our analysis of gestational age, although regression analy-
sis is robust to the normality assumption [67]. To investigate whether it could be a significant
problem, we tested the association between the nontransmitted haplotype score and gestational
age using a nonparametric method, and the results showed similar significant association
(meta p = 0.0053). In addition, we performed the same analysis only in term mother/child
pairs (in which the gestational age followed a truncated distribution but did not significantly
deviate from normal) and obtained similar results (meta p-v = 0.0270 for the association
between gestational age and the maternal nontransmitted haplotype score).
Another potential problem is the differences in phenotype data collection and availability
among the three studies. For example, gestational age at birth was estimated by last menstrual
period in DNBC but by ultrasound in the MoBa and FIN studies, and birth length was unavail-
able in DNBC. In addition, the high missing rates in some of participant studies also prevented
us from including some known important covariates like maternal BMI, smoking, and parity
in the regression models. However, in the individual studies in which these variables were
available, the analytical results from models with or without these covariates did not show sig-
nificant differences. Therefore, we believe the major findings of our study are solid and robust
to these limitations.
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Conclusion
In summary, this study defines the causal relationship for the strong association of maternal
height with fetal growth measures (i.e., birth length and birth weight) and gestational age at
birth. The observed association between maternal height and fetal growth parameters is mainly
defined by fetal genetics, and many of the adult height-associated SNPs also influence fetal
growth. In contrast, the association between maternal height and gestational age more likely
reflects the maternal height phenotype, and the resulting fetal growth environment it shapes, as
being deterministic. In addition, our approach that utilizes the genetic score derived from the
parental nontransmitted haplotype as a genetic instrument is a novel extension to the Mende-
lian randomization methodology in casual inference between parental exposure and outcomes
in offspring.
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Editors' Summary
Background
Soon after the birth of a baby, doting parents send messages to friends and relatives or
post information on social media sites to let everyone know when their new baby boy or
girl was born. They may also post information about how heavy he/she was at birth and
his/her length. These pregnancy outcomes, together with gestational age at birth (the
length of time that a baby has spent developing in its mother’s womb), affect the baby’s
immediate health and survival. Importantly, however, these pregnancy outcomes are also
associated with the risk of long-term adverse health outcomes such as obesity, cardiometa-
bolic disorders (heart disease and conditions such as diabetes that affect how the body
makes energy from food), and neuropsychiatric conditions (mental disorders attributable
to diseases of the nervous system, such as depression). For example, some studies have
shown an association between low birth weight and an increased risk of type 2 diabetes
later in life.
WhyWas This Study Done?
Identification of the environmental and genetic factors that causally influence gestational
age, length, and weight at birth would improve our understanding of why these pregnancy
outcomes are associated with disease during adulthood and could help in the design of
strategies to prevent these diseases. Epidemiological studies (investigations that examine
disease patterns in populations) suggest that, compared to tall mothers, short mothers
tend to deliver their babies at earlier gestational ages, with lower birth weights and lengths.
Epidemiological studies cannot show, however, whether variations in maternal height
cause variations in pregnancy outcomes. Other characteristics shared by tall mothers
might actually determine the size and gestational age of their offspring (confounding).
Here, the researchers use “Mendelian randomization” to assess the causal effect of mater-
nal height on the size and gestational age at birth of babies. Because gene variants are
inherited randomly, they are not prone to confounding. So, if maternal height actually
affects gestational age and size at birth, genetic variants (instruments) that affect maternal
height should be associated with differences in gestational age and size at birth, provided
confounding due to the transmission of parental alleles (variant forms of genes; people
have two alleles of every gene, one inherited from each parent) is avoided by adjusting for
the baby’s genotype.
What Did the Researchers Do and Find?
The researchers used phenotype data (observable characteristics such as maternal height
and birth weight of the baby) and single nucleotide polymorphism (SNP; a type of genetic
variant) data obtained from 3,486 Nordic mother/baby pairs. Analysis of the phenotype
data indicated that maternal height was significantly associated with length, weight, and
gestational age at birth (a significant association is unlikely to have arisen by chance). For
their Mendelian randomization analysis, the researchers constructed a genetic score based
on 697 SNPs known to be associated with adult height. To avoid confounding due to
genetic sharing between the mother and baby, they determined which of the height-associ-
ated alleles each baby had inherited from its mother and used the nontransmitted haplo-
type score as a genetic instrument for maternal height (a haplotype is a set of DNA
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variations that are inherited together). Birth length and weight were significantly associ-
ated with both the maternal and paternal transmitted haplotype scores but not with the
maternal nontransmitted haplotype score. However, gestational age was significantly but
modestly associated with the maternal nontransmitted haplotype score.
What Do These Findings Mean?
The validity of the assumptions that underlie the Mendelian randomization approach and
the design of the studies supplying the data for this analysis may affect the accuracy of the
findings reported here. Nevertheless, these findings suggest that the observed association
between maternal height and fetal growth measurements is mainly determined by the
genetics of the baby. That is, differences in maternal height do not cause differences in
birth weight or length. Rather, some of the gene variants that the baby inherits from its
mother determine both its size and its mother’s height. These findings also provide weak
evidence that the association between maternal height and gestational age is causal. Mater-
nal height might, for example, causally influence gestational age by limiting the space
available for the baby’s growth before birth. Finally, these findings introduce an extension
to the Mendelian randomization approach that can be used to investigate causal associa-
tions between parental characteristics and offspring outcomes.
Additional Information
This list of resources contains links that can be accessed when viewing the PDF on a device
or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001865.
• The March of Dimes, a not-for-profit organization for pregnancy and baby health, pro-
vides information about low birth weight and its consequences
• Nemours, a not-for-profit organization for child health, provides information about the
weight of newborn babies (in English and Spanish)
• Wikipedia has pages on birth weight, gestational age, and Mendelian randomization
(note: Wikipedia is a free online encyclopedia that anyone can edit; available in several
languages)
• MedlinePlus provides information and links to additional resources about birth weight
and a brief explanation of gestational age (in English and Spanish)
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